Manila City begins inoculating medical frontliners with Sputnik V | Inquirer News

Manila City begins inoculating medical frontliners with Sputnik V

By: - Reporter / @zacariansINQ
/ 02:15 PM May 04, 2021

MANILA, Philippines —  The local government of Manila on Tuesday said that it has already started inoculating its medical frontliners with the Russian-made vaccine, Sputnik V.

Manila Vice Mayor and Doctor Maria Sheilah “Honey” Lacuna-Pangan said medical frontliners will be jabbed first before proceeding to other priority groups set by the Department of Health (DOH) and the Inter-Agency Task Force.

“Gaya na rin po ng bilin ng ating alkade, Mayor Isko Moreno, susundin po namin yung category na inilatag po satin ng IATF at ng DOH. So magsisimula po tayo sa medical frontliners, yung mga A1,” Lacuna-Pangan said in a statement.

Article continues after this advertisement

(As instructed by our mayor, Mayor Isko Moreno, we will follow the category set for us by the IATF and the DOH. So will start with the medical frontliners, the A1.)

FEATURED STORIES

“Pagkatapos po nun, kung wala na pong nag-aavail in how many days time siguro in 2-3 days, ay ibibigay na po natin yan sa susunod na category,” she added.

(After that, if no one will avail of the vaccine in the next 2-3 days, we will give it to the next category.)

Article continues after this advertisement

As of 12:00 p.m., about 59 medical frontliners have already been vaccinated using the Sputnik V vaccine.

Article continues after this advertisement

The city first received the 3,000 doses of Sputnik V on Monday, May 3.

Article continues after this advertisement

Manila City Health Officer Dr. Arnold Pangan said the vials are sufficient to vaccinate 3,000 medical frontliners from the six district hospitals and national government hospitals in the city.

About 79,593 medical frontliners, senior citizens, and those with comorbidities have been vaccinated by the Manila City government as of 6:00 pm on Monday, May 3.

Article continues after this advertisement

Out of this number, 25,341 have already received their second dose.

The said vaccines which were produced by the Gamaleya Research Institute of Epidemiology and Microbiology, first arrived in the country after it has received a total of 15,000 doses of Sputnik V, the first batch of the 20 million doses the Philippines is eyeing to procure.

DOH said the first batch of Sputnik V would be distributed in seven vaccination sites in Metro Manila.

According to the Food and Drug Administration, the efficacy rate of Sputnik V is at 91.6 percent and is authorized to be used in 64 countries with a total population of over 3.2 billion people.

The reported side effects for the said vaccine include flu-like symptoms, arm soreness, and headaches.

Sputnik V also requires two doses, much like the other vaccines currently available in the country.

RELATED STORY

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

DOH not dropping Sputnik V despite Brazil rejection; 15,000 doses arrive

JE

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Manila City, Sputnik V

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.